CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 60 filers reported holding CYTOSORBENTS CORP in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,180 | -47.6% | 23,500 | 0.0% | 0.01% | -42.1% |
| Q2 2023 | $84,365 | +25.2% | 23,500 | +17.5% | 0.02% | +18.8% |
| Q1 2023 | $67,400 | +117.4% | 20,000 | 0.0% | 0.02% | +100.0% |
| Q4 2022 | $31,000 | +106.7% | 20,000 | +81.8% | 0.01% | +100.0% |
| Q3 2022 | $15,000 | -37.5% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -31.4% | 11,000 | +175.0% | 0.00% | -42.9% |
| Q1 2021 | $35,000 | -37.5% | 4,000 | -42.9% | 0.01% | -46.2% |
| Q4 2020 | $56,000 | 0.0% | 7,000 | 0.0% | 0.01% | -7.1% |
| Q3 2020 | $56,000 | -18.8% | 7,000 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $69,000 | +27.8% | 7,000 | 0.0% | 0.03% | +8.3% |
| Q1 2020 | $54,000 | – | 7,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |